JAMA Most Cited http://www.elizeaboutbeauty.com/journals/jama The Most Cited articles published by JAMA en-us Mon, 19 Apr 2021 14:43:29 GMT Mon, 19 Apr 2021 14:43:29 GMT Silverchair jamams@jamanetwork.org support@www.elizeaboutbeauty.com Clinical Characteristics of Patients With 2019 Novel Coronavirus (2019-nCoV)–Infected Pneumonia in Wuhan, China http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2761044 Tue, 17 Mar 2020 00:00:00 GMT Wang D, Hu B, Hu C, et al. This single-center case series describes the demographics, symptoms, laboratory and imaging findings, treatment, and clinical course of 138 patients hospitalized with 2019 novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) in Wuhan, China, highlighting presumed human-to-human hospital-associated transmission in many cases. 323 11 1061 1069 10.1001/jama.2020.1585 2761044 The Coronavirus Disease 2019 (COVID-19) Outbreak in China—Summary of a China CDC Report http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762130 Tue, 07 Apr 2020 00:00:00 GMT Wu Z, McGoogan JM. This Viewpoint summarizes key epidemiologic and clinical findings from all cases of coronavirus disease 2019 (COVID-19) reported through February 11, 2020, in mainland China, and case trends in response to government attempts to control and contain the infection. 323 13 1239 1242 10.1001/jama.2020.2648 2762130 Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in the NYC Area http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2765184 Tue, 26 May 2020 00:00:00 GMT Richardson S, Hirsch JS, Narasimhan M, et al. This case series describes clinical characteristics, health services use, and outcomes of patients with confirmed coronavirus disease 2019 (COVID-19) cared for at 12 hospitals of a single health system in the New York City (NYC) area. 323 20 2052 2059 10.1001/jama.2020.6775 2765184 Clarification of Mortality Rate and Data in Abstract, Results, and Table 2 http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2765367 Tue, 26 May 2020 00:00:00 GMT In the Original Investigation titled “Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area?published online April 22, 2020, in JAMA, clarification and correction of data were required. In the Abstract, Results paragraph, the sentence reporting mortality for patients receiving mechanical ventilation should read, “As of April 4, 2020, for patients requiring mechanical ventilation (n = 1151, 20.2%), 38 (3.3%) were discharged alive, 282 (24.5%) died, and 831 (72.2%) remained in hospital.?This same sentence was added to the second paragraph of the Results section in the text. In the first paragraph of the text Results, the sentence about test results should read, “The first test for COVID-19 was positive in 5517 patients (96.8%), while 183 patients (3.2%) had a negative first test and positive repeat test.?In the Discussion, a paragraph was added to clarify the calculation of mortality rates. In Table 2, the number (%) of patients with concurrent entero/rhinovirus infection should be ?2 (52.4).?This article has been corrected online. 323 20 2098 2098 10.1001/jama.2020.7681 2765367 Detection of SARS-CoV-2 in Different Types of Clinical Specimens http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762997 Tue, 12 May 2020 00:00:00 GMT Wang W, Xu Y, Gao R, et al. This study describes results of PCR and viral RNA testing for SARS-CoV-2 in bronchoalveolar fluid, sputum, feces, blood, and urine specimens from patients with COVID-19 infection in China to identify possible means of non-respiratory transmission. 323 18 1843 1844 10.1001/jama.2020.3786 2762997 Characteristics and Outcomes of Patients Infected With SARS-CoV-2 Admitted to ICUs in Italy http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2764365 Tue, 28 Apr 2020 00:00:00 GMT Grasselli G, Zangrillo A, Zanella A, et al. This case series describes the demographics, comorbidities, ventilation requirements, dispositions, and mortality of patients with PCR-confirmed SARS-CoV-2 infection admitted to northern Italy ICUs in February-March 2020.. 323 16 1574 1581 10.1001/jama.2020.5394 2764365 Presumed Asymptomatic Carrier Transmission of COVID-19 http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762028 Tue, 14 Apr 2020 00:00:00 GMT Bai Y, Yao L, Wei T, et al. This study describes possible transmission of novel coronavirus disease 2019 (COVID-19) from an asymptomatic Wuhan resident to 5 family members in Anyang, a Chinese city in the neighboring province of Hubei. 323 14 1406 1407 10.1001/jama.2020.2565 2762028 COVID-19 Case-Fatality Rate and Characteristics of Patients Dying in Italy http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763667 Tue, 12 May 2020 00:00:00 GMT Onder G, Rezza G, Brusaferro S. This Viewpoint from physicians with the Italian National Institute of Health confirms a higher case-fatality rate from coronavirus disease 2019 (COVID-19) in Italy compared with China and explains possible reasons, including age, cause of death definitions, and testing strategy. 323 18 1775 1776 10.1001/jama.2020.4683 2763667 Treatment of Critically Ill Patients With COVID-19 With Convalescent Plasma http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763983 Tue, 28 Apr 2020 00:00:00 GMT Shen C, Wang Z, Zhao F, et al. This case series describes clinical outcomes in 5 Chinese patients with laboratory-confirmed COVID-19, ARDS, and high viral loads despite antiviral treatment who were given human plasma with SARS-CoV-2 antibodies obtained from previously infected and recovered patients. 323 16 1582 1589 10.1001/jama.2020.4783 2763983 Physical Activity Guidelines for Americans http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2712935 Tue, 20 Nov 2018 00:00:00 GMT Piercy KL, Troiano RP, Ballard RM, et al. This Special Communication from the US Department of Health and Human Services summarizes key guidelines and recommendations in the Physical Activity Guidelines for Americans, 2nd edition. 320 19 2020 2028 10.1001/jama.2018.14854 2712935 Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2764727 Tue, 12 May 2020 00:00:00 GMT Sanders JM, Monogue ML, Jodlowski TZ, et al. This narrative review summarizes what is currently known about how SARS-CoV-2 infects cells and causes disease as a basis for considering whether chloroquine, remdisivir and other antivirals, or other existing drugs might be effective treatment for coronavirus disease 2019 (COVID-19). 323 18 1824 1836 10.1001/jama.2020.6019 2764727 Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762688 Tue, 21 Apr 2020 00:00:00 GMT Young B, Ong S, Kalimuddin S, et al. This case series describes the epidemiologic features, clinical presentation, treatment, and outcomes of the first 18 patients with confirmed coronavirus disease 2019 (COVID-19) in Singapore 323 15 1488 1494 10.1001/jama.2020.3204 2762688 Characteristics and Outcomes of Critically Ill Patients With COVID-19 in Washington State http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763485 Tue, 28 Apr 2020 00:00:00 GMT Arentz M, Yim E, Klaff L, et al. This case series describes the clinical presentation, characteristics, and outcomes of patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit at a public hospital in Washington State in February 2020, including initial reports of cardiomyopathy in one-third of the patients. 323 16 1612 1614 10.1001/jama.2020.4326 2763485 Trends in Obesity Prevalence in US Youth and Adults, 2007-2008 to 2015-2016 http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2676543 Tue, 24 Apr 2018 00:00:00 GMT Hales CM, Fryar CD, Carroll MD, et al. This study uses National Health and Nutrition Examination Survey data to characterize trends in obesity prevalence among US youth and adults between 2007-2008 and 2015-2016. 319 16 1723 1725 10.1001/jama.2018.3060 2676543 SARS-CoV-2 Contamination of Air, Environmental Surfaces, and Personal Protective Equipment http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762692 Tue, 28 Apr 2020 00:00:00 GMT Ong S, Tan Y, Chia P, et al. This study documents results of SARS-CoV-2 polymerase chain reaction (PCR) testing of environmental surfaces and personal protective equipment surrounding 3 COVID-19 patients in isolation rooms in a Singapore hospital. 323 16 1610 1612 10.1001/jama.2020.3227 2762692 Critical Care and the COVID-19 Outbreak in Italy: Early Experience and Forecast http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763188 Tue, 28 Apr 2020 00:00:00 GMT Grasselli G, Pesenti A, Cecconi M. This Viewpoint describes the organization of a regional ICU network in Lombardy, Italy, to handle the surge in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who require intensive care and uses demand experience in the first 2 weeks of the outbreak to estimate resources required in coming weeks. 323 16 1545 1546 10.1001/jama.2020.4031 2763188 Coronavirus Infections—More Than Just the Common Cold http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2759815 Tue, 25 Feb 2020 00:00:00 GMT Paules CI, Marston HD, Fauci AS. In this Viewpoint Anthony Fauci and colleagues review the emergence of pathogenic human coronaviruses (SARS-Cov and MERS-CoV) as background for discussing a rapidly spreading novel coronavirus (2019-nCoV) identified in 2019 in China and the public health strategies necessary to contain the threat. 323 8 707 708 10.1001/jama.2020.0757 2759815 COVID-19, African Americans, and Health Disparities http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2764789 Tue, 19 May 2020 00:00:00 GMT Yancy CW. This Viewpoint discusses the long history of racial inequities that cause black populations in US cities to bear a disproportionate burden of COVID-19 illness and mortality and calls for a renewed commitment to eliminating disparities that have been made so starkly visible by the pandemic. 323 19 1891 1892 10.1001/jama.2020.6548 2764789 Breast Cancer Treatment in 2019 http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2721183 Tue, 22 Jan 2019 00:00:00 GMT Waks AG, Winer EP. This narrative review summarizes current evidence-based approaches to local and systemic treatment of hormone receptor positive/ERBB2 negative (HR+/ERBB2?, ERBB2 positive (ERBB2+), and triple-negative breast cancer. 321 3 288 300 10.1001/jama.2018.19323 2721183 Effect of Linagliptin vs Placebo on Major Cardiovascular Events in High-Risk Adults With Diabetes http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2714646 Tue, 01 Jan 2019 00:00:00 GMT Rosenstock J, Perkovic V, Johansen O, et al. This randomized clinical trial compares the effects of the dipeptidyl peptidase 4 inhibitor linagliptin vs placebo plus usual care on cardiovascular (CV) and renal outcomes in adults with type 2 diabetes and high CV and renal risk. 321 1 69 79 10.1001/jama.2018.18269 2714646 Coronavirus Disease 2019 (COVID-19)—Epidemiology, Diagnosis, and Treatment http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2768391 Tue, 25 Aug 2020 00:00:00 GMT Wiersinga W, Rhodes A, Cheng AC, et al. This narrative review discusses what is currently known about the pathophysiology, epidemiology, diagnosis, management, prognosis, and prevention of coronavirus disease 2019 (COVID-19). 324 8 782 793 10.1001/jama.2020.12839 2768391 Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763853 Tue, 12 May 2020 00:00:00 GMT Dong L, Tian J, He S, et al. This case report describes birth of an infant with elevated anti–SARS-CoV-2 IgM antibodies and cytokine levels to a mother with polymerase chain reaction–confirmed coronavirus disease 2019 (COVID-19) despite no physical contact. 323 18 1846 1848 10.1001/jama.2020.4621 2763853 Treatment With Hydroxychloroquine or Azithromycin and In-Hospital Mortality in Patients With COVID-19 http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2766117 Tue, 23 Jun 2020 00:00:00 GMT Rosenberg ES, Dufort EM, Udo T, et al. This study examines associations between use of hydroxychloroquine, azithromycin, or both and in-hospital mortality, ECG changes, and cardiac arrest among patients with COVID-19 hospitalized in the metropolitan New York area in March 2020. 323 24 2493 2502 10.1001/jama.2020.8630 2766117 Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762689 Tue, 14 Apr 2020 00:00:00 GMT Wang C, Ng CY, Brook RH. This Viewpoint describes the outbreak response infrastructure developed by the Taiwanese government following the SARS epidemic in 2003 and actions in response to COVID-19, including dedicated hotlines for symptom reporting, mobile phone messaging and case tracking, and the ramping up of facemask production. 323 14 1341 1342 10.1001/jama.2020.3151 2762689 Public Health Interventions and Epidemiology of the COVID-19 Outbreak in Wuhan, China http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2764658 Tue, 19 May 2020 00:00:00 GMT Pan A, Liu L, Wang C, et al. This population epidemiology study examines associations between phases of nonpharmaceutical public health interventions (social distancing, centralized quarantine, home confinement, and others) and rates of laboratory-confirmed COVID-19 infection in Wuhan, China, between December 2019 and early March 2020. 323 19 1915 1923 10.1001/jama.2020.6130 2764658 Interpreting Diagnostic Tests for SARS-CoV-2 http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2765837 Tue, 09 Jun 2020 00:00:00 GMT Sethuraman N, Jeremiah S, Ryo A. This Viewpoint discusses the 2 most common categories of testing to diagnose SARS-CoV-2—real-time PCR to identify viral RNA and serological diagnosis of IgG and IgM antibodies to assess immune response—and estimates time intervals for test positivity by specimen source to help clinicians interpret results relative to symptom onset. 323 22 2249 2251 10.1001/jama.2020.8259 2765837 Supporting the Health Care Workforce During the COVID-19 Global Epidemic http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763136 Tue, 21 Apr 2020 00:00:00 GMT Adams JG, Walls RM. This Viewpoint discusses the importance of protecting health care workers caring for patients with coronavirus disease 2019 (COVID-19) and measures that can be taken in and out of the hospital to prevent their and their families?exposure to SARS-CoV-2. 323 15 1439 1440 10.1001/jama.2020.3972 2763136 COVID-19 and Racial/Ethnic Disparities http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2766098 Tue, 23 Jun 2020 00:00:00 GMT Webb Hooper M, N֙poles A, Pérez-Stable EJ. This Viewpoint reviews possible reasons for reported excess mortality and poor outcomes in racial/ethnic minority populations with COVID-19 and proposes research, public health, and clinical interventions to decrease health inequities in and beyond the pandemic. 323 24 2466 2467 10.1001/jama.2020.8598 2766098 The 2019 Novel Coronavirus and Challenges for Global Health Governance http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2760500 Tue, 25 Feb 2020 00:00:00 GMT Phelan AL, Katz R, Gostin LO. In this Viewpoint, Gostin and colleagues review the emerging novel coronavirus (2019-nCoV) outbreak, discuss the public health benefits and risks of the Chinese government’s large city quarantines, and call for WHO leadership to coordinate a global coordinated response that could contain this and prevent similar future outbreaks. 323 8 709 710 10.1001/jama.2020.1097 2760500 Turbulent Gas Clouds and Respiratory Pathogen Emissions http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763852 Tue, 12 May 2020 00:00:00 GMT Bourouiba L. This JAMA Insights Clinical Update discusses the need to better understand the dynamics of respiratory disease transmission by better characterizing transmission routes, the role of patient physiology in shaping them, and best approaches for source control in the context of the COVID-19 outbreak. 323 18 1837 1838 10.1001/jama.2020.4756 2763852 4887王中王鉄算 盘开奖结果小说